Intelligence / Healthtech / Health Funding Register
FundingLIVEUpdated 30 Sept 2026
Health Funding Register
Every new private funding round filed with the SEC by US health, biotech and pharma companies.
Sources: SEC Form D · Rebuilt weekly · New Form D notices filed in Q3 2026 by health and life-sciences companies; pooled investment funds and amendments excluded. Amounts are as reported to the SEC.
Companies
392
in Q3 2026
Added in 30 days
137
to 30 Sept 2026
Top state
California
66 · 17% of the list
Raised in total
$4.0B
as reported to the SEC
Snapshot · 30 Sept 2026
Explore all 392 Growth
By month
392
Signals
What the register says this week, and why it matters if you sell into it.
- 137 added in the 30 days to 30 Sept 2026.
- 114 of them (29%) raised $5M or more.
- California leads with 66 raises, followed by Massachusetts (39).
- Companies buy in the months after they raise: new hires, new vendors, new markets.
FiledCompanyLocationIndustryRaised
28 Sept 2026Q-Immune, Inc.Seattle, WASeattle, WABiotechnology$25K22 Sept 2026Seattle Neurosound Solutions, Inc.Seattle, WASeattle, WAOther Health Care$100K15 Sept 2026Hexamer Therapeutics, IncPullman, WAPullman, WABiotechnology$500K14 Sept 2026DexCare, Inc.Seattle, WASeattle, WAOther Health Care$12.9M26 Aug 2026Aptevo Therapeutics Inc.Seattle, WASeattle, WAPharmaceuticals$3.5M25 Aug 2026MalarVx, Inc.Seattle, WASeattle, WABiotechnology$125K14 Aug 2026Strella Biotechnology, Inc.Seattle, WASeattle, WABiotechnology$1.8M7 Aug 2026Automera US Inc.Seattle, WASeattle, WABiotechnology$1.0M28 Jul 2026Accipiter Biosciences Inc.Seattle, WASeattle, WABiotechnology$10.5M13 Jul 2026Pluristyx Inc.Seattle, WASeattle, WABiotechnology$9.8M// How AOS uses this